Home » News » India to import 4,50,000 vials of Remdesivir

India to import 4,50,000 vials of Remdesivir

The Government of India has started importing the vital drug Remdesivir from other countries to ease out the shortage of Remdesivir in the country. The first Consignment of 75000 vials will reach India today.

HLL Lifecare Ltd, a Government of India owned company has ordered 4,50,000 vials of Remdesivir  from M/s Gilead Sciences Inc USA. and Egyptian Pharma Company, M/s Eva Pharma.  It is expected that Gilead Sciences Inc. USA will dispatch 75,000 to 1,00,000 vials in the next one or two days. Further one hundred thousand quantities will also be supplied before or by May 15. EVA pharma will supply approximately 10,000 vials initially followed by 50,000 vials every 15 days or till July.

Government has ramped up the production capacity of Remdesivir in the country. As on 27.04.21, the production capacity of the seven licensed domestic manufacturers increased from 38 lakh vials per month to 1.03 crore vials per month. Total 13.73 lakh vials have been supplied across the country by the Drug companies in the last seven days (21-28 April, 2021). The daily supply has gone up from 67,900 vials on 11th April to 2.09 lakh vials on 28th April, 2021. An advisory was issued by MHA to states and UTs to facilitate smooth movement of Remdesivir supplies.

Government also prohibited the export of Remdesivir to enhance its availability in India. To ensure affordability of the injection among the masses, NPPA on April 17, 2021 released the revised maximum retail price thus bringing down the cost of all the major brands to below Rs 3500 per vial.

In order to facilitate higher production and availability of Remdesivir, the Department of Revenue vide Notification 27/2021-Customs dated 20th April exempted the whole of the duty of Customs  on Remdesivir injection, its API and Beta cyclodextrin used in manufacture of Remdesivir, till 31st October 2021.

National Treatment Protocol was updated through the Clinical guidance for Management of Adult COVID 19 patients by AIIMS/ ICMR- COVID-19 National Task Force/ Joint Monitoring group of MoHFW on 22.04.2021. The updated protocol will encourage Judicious use of Drugs and is expected to contribute to rationalising demand.

 

About IIPnews

Leave a Reply

Your email address will not be published. Required fields are marked *

*

x

Check Also

iCreate, Microsoft and MeitY Join Hands to Transform & Boost Indian Startups in AI

During his address the Minister said, “The MoU signing for the partnership between Microsoft and ...

Digi Yatra app users number crosses 45.8 Lakhs

The number of passengers having installed the Digi Yatra application on their mobile phones has ...

Growth of 42.85% in Passengers Carried by Domestic Airlines

Remarkable growth in the number of passengers carried by domestic airlines has been noticed. According ...

Union Budget to give a boost to exports and manufacturing

Union Budget 2023-24 has a slew of measures to give boost to exports and help ...

Shri Jyotiraditya Scindia inaugurates flight connecting Bhubaneswar, Kolkata, and Jamshedpur

Union Minister of Civil Aviation and Steel, Shri Jyotiraditya M. Scindia along with General Dr. ...

Margin Money worth Rs. 100.29 Crore distributed among 3223 beneficiaries Under PMEGP Scheme , 26000 new employment generated

Chairman, Khadi and Village Industries Commission Shri Manoj Kumar today released  margin money grant of ...

G20-Startup20 Engagement Group set to meet in Hyderabad; India to convene global support for start-ups, strengthen ecosystem synergies

The G20 Startup20 Engagement Group will hold its inception meeting in Hyderabad this week, featuring ...

Regulation of Digital Media

To help achieve the aim of making Internet Open, Safe and Trusted and Accountable and ...

Roundtable of Secretary, M/o Food Processing Industries with Central Ministries and Government Departments on activities related to IYOM & Mega Food Event 2023

Secretary, Ministry of Food Processing Industries, Smt Anita Praveen chaired a roundtable interaction with senior ...

Under Phase-II of FAME India Scheme, 7,45,713 Electric Vehicles supported till 07 Dec 2022 by way of Demand Incentive amounting to about Rs. 3,200 Cr.

Under Phase-II of FAME India Scheme, 7,45,713 Electric Vehicles have been supported till 07.12.2022 by ...

WP2Social Auto Publish Powered By : XYZScripts.com